{"id":1067984,"date":"2020-10-30T21:57:57","date_gmt":"2020-10-31T01:57:57","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/mhra-grants-hae-patients-early-access-to-biocrysts-berotralstat-in-united-kingdom\/"},"modified":"2024-08-18T11:41:37","modified_gmt":"2024-08-18T15:41:37","slug":"mhra-grants-hae-patients-early-access-to-biocrysts-berotralstat-in-united-kingdom","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/mhra-grants-hae-patients-early-access-to-biocrysts-berotralstat-in-united-kingdom.php","title":{"rendered":"MHRA Grants HAE Patients Early Access to BioCryst\u2019s Berotralstat in United Kingdom"},"content":{"rendered":"<p><![CDATA[RESEARCH TRIANGLE PARK, N.C., Oct.  30, 2020  (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the United Kingdom\u2019s Medicines and Healthcare products Regulatory Agency (MHRA) has granted oral, once-daily berotralstat a positive scientific opinion through the Early Access to Medicines Scheme (EAMS).]]><\/p>\n<p>Go here to see the original:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener noreferrer\" href=\"http:\/\/www.globenewswire.com\/news-release\/2020\/10\/30\/2117755\/0\/en\/MHRA-Grants-HAE-Patients-Early-Access-to-BioCryst-s-Berotralstat-in-United-Kingdom.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"MHRA Grants HAE Patients Early Access to BioCryst\u2019s Berotralstat in United Kingdom\">MHRA Grants HAE Patients Early Access to BioCryst\u2019s Berotralstat in United Kingdom<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Go here to see the original: MHRA Grants HAE Patients Early Access to BioCryst\u2019s Berotralstat in United Kingdom <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/mhra-grants-hae-patients-early-access-to-biocrysts-berotralstat-in-united-kingdom.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-1067984","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1067984"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1067984"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1067984\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1067984"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1067984"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1067984"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}